1. Home
  2. GLPG vs KWR Comparison

GLPG vs KWR Comparison

Compare GLPG & KWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLPG
  • KWR
  • Stock Information
  • Founded
  • GLPG 1999
  • KWR 1918
  • Country
  • GLPG Belgium
  • KWR United States
  • Employees
  • GLPG N/A
  • KWR N/A
  • Industry
  • GLPG Biotechnology: Pharmaceutical Preparations
  • KWR Major Chemicals
  • Sector
  • GLPG Health Care
  • KWR Industrials
  • Exchange
  • GLPG Nasdaq
  • KWR Nasdaq
  • Market Cap
  • GLPG 1.8B
  • KWR 2.0B
  • IPO Year
  • GLPG 2005
  • KWR 1985
  • Fundamental
  • Price
  • GLPG $27.87
  • KWR $116.64
  • Analyst Decision
  • GLPG Sell
  • KWR Strong Buy
  • Analyst Count
  • GLPG 4
  • KWR 5
  • Target Price
  • GLPG $25.33
  • KWR $155.40
  • AVG Volume (30 Days)
  • GLPG 259.2K
  • KWR 186.4K
  • Earning Date
  • GLPG 07-23-2025
  • KWR 08-04-2025
  • Dividend Yield
  • GLPG N/A
  • KWR 1.67%
  • EPS Growth
  • GLPG N/A
  • KWR N/A
  • EPS
  • GLPG N/A
  • KWR 5.29
  • Revenue
  • GLPG $311,493,731.00
  • KWR $1,812,841,000.00
  • Revenue This Year
  • GLPG $0.78
  • KWR $1.16
  • Revenue Next Year
  • GLPG N/A
  • KWR $5.32
  • P/E Ratio
  • GLPG N/A
  • KWR $21.77
  • Revenue Growth
  • GLPG 18.32
  • KWR N/A
  • 52 Week Low
  • GLPG $22.36
  • KWR $95.91
  • 52 Week High
  • GLPG $31.23
  • KWR $193.74
  • Technical
  • Relative Strength Index (RSI)
  • GLPG 51.86
  • KWR 57.46
  • Support Level
  • GLPG $26.62
  • KWR $113.46
  • Resistance Level
  • GLPG $29.28
  • KWR $117.63
  • Average True Range (ATR)
  • GLPG 0.58
  • KWR 3.37
  • MACD
  • GLPG -0.16
  • KWR -0.05
  • Stochastic Oscillator
  • GLPG 54.51
  • KWR 41.96

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

About KWR Quaker Houghton

Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.

Share on Social Networks: